Consistencia interna y estructura factorial de la Escala de Desesperanza de Beck en estudiantes mexicanos

Background The death of a loved one was a challenge many people faced during the COVID-19 pandemic within the context of extraordinary circumstances and great uncertainty. Grief is an unavoidable part of life, and for most people, feelings of grief decrease naturally over time. However, for some people, grieving can become a particularly painful process with clinical symptoms that may require professional help to resolve. To provide psychological support to people who had lost a loved one during the COVID-19 pandemic, an unguided web-based psychological intervention was developed. Objective The main objective of this study was to evaluate the efficacy of the web-based treatment, Grief COVID (Duelo COVID in Spanish; ITLAB), in reducing clinical symptoms of complicated grief, depression, posttraumatic stress, hopelessness, anxiety, and suicidal risk in adults. The secondary aim was to validate the usability of the self-applied intervention system. Methods We used a randomized controlled trial with an intervention group (IG) and a waitlist control group (CG). The groups were assessed 3 times (before beginning the intervention, upon completing the intervention, and 3 months after the intervention). The intervention was delivered on the web in an asynchronous format through the Duelo COVID web page. Participants created an account that could be used on their computers, smartphones, or tablets. The evaluation process was automated as part of the intervention. Results A total of 114 participants were randomly assigned to the IG or CG and met criteria for inclusion in the study (n=45, 39.5% completed the intervention and n=69, 60.5% completed the waitlist period). Most participants (103/114, 90.4%) were women. The results indicated that the treatment significantly reduced baseline clinical symptoms in the IG for all variables (P<.001 to P=.006), with larger effect sizes for depression, hopelessness, grief, anxiety, and risk of suicide (all effect sizes ≥0.5). The follow-up evaluation showed that symptom reduction was maintained at 3 months after the intervention. The results from the CG showed that participants experienced significantly decreased levels of hopelessness after completing the time on the waitlist (P<.001), but their suicidal risk scores increased. Regarding the usability of the self-applied intervention system, the results indicated a high level of satisfaction with the Grief COVID. Conclusions The self-applied web-based intervention Grief COVID was effective in reducing symptoms of anxiety, depression, hopelessness, risk of suicide risk, posttraumatic stress disorder, and complicated grief disorder. Grief COVID was evaluated by the participants, who reported that the system was easy to use. These results affirm the importance of developing additional web-based psychological tools to help reduce clinical symptoms in people experiencing grief because of the loss of a loved one during a pandemic. Trial Registration ClinicalTrials.gov NCT04638842; https://clinicaltrials.gov/ct2/show/NCT04638842

show abstract

“…It is a widely validated and used scale. For this study, the version validated in the Mexican population was applied [ 46 ].…”

Section: Methodsmentioning

confidence: 99%

The Efficacy and Usability of an Unguided Web-Based Grief Intervention for Adults Who Lost a Loved One During the COVID-19 Pandemic: Randomized Controlled Trial

Domínguez-Rodríguez¹,

Sanz²,

González-Ramírez³

et al. 2023

J Med Internet Res

View full text Add to dashboard Cite

show abstract

“…Beck’s Depression Questionnaire measures the presence and severity of depression symptoms; it is self-administered among adults through 21 responses with a Likert-type scale that ranges from 0 to 3, assessing the intensity of each symptom, and among the Mexican population, it has an Alpha Cronbach of 0.92 ( Córdova Osnaya and Rosales Perez, 2011 ).…”

Section: Methodsmentioning

confidence: 99%

“…The total is the sum of the points of all the items. A score equal to or over 6 indicates the presence of suicide risk ( Córdova Osnaya and Rosales Perez, 2011 ; Santana-Campas and Santoyo Telles, 2018 ).…”

Section: Methodsmentioning

confidence: 99%

Depression symptoms and suicide risk of internal medicine residents before and after first year of the COVID-19 pandemic

De La Roca-Chiapas,

Grajeda Gutiérrez,

Íñiguez Venegas

et al. 2023

Front. Psychol.

View full text Add to dashboard Cite

IntroductionDepression is a mental health disorder characterized by the presence of sadness or loss of the ability to feel pleasure, with a high incidence in patients with COVID 19. The investigations have focused on patient care and little on the care of health personnel, these being the ones with the highest mortality rate, so the objective of the study was to investigate the prevalence of depression symptoms and suicide risk and understand the association of depressive disorder and suicide risk with levels of serum cholesterol and low levels of serum cortisol among internal medicine fellows in a specialist medical hospital in Leon, Guanajuato, Mexico, before and after COVID-19.MethodsIn this longitudinal study, internal medicine residents were initially monitored for 2months before starting to care for patients with COVID-19. Participants were asked to fill out depression symptoms and suicide risk surveys. We measured the serum cholesterol and cortisol of each participant, and again after 11months of treating COVID-19 patients.ResultsDepression symptoms and suicide risk were assessed; significant differences were found between the two time periods for depression (p < 0.01), and no difference was found for suicide risk (p = 0.182). We found a significant correlation between serum cholesterol levels and suicide risk (r = 0.366, p < 0.01); we also found differences in serum cortisol levels (p < 0.01) and cholesterol (p < 0.0001) before and after the pandemic.ConclusionCaring for patients with COVID-19 in the hospital contributed to an increase in levels of depression symptoms and suicidal ideation, as well as differences in levels of cortisol and cholesterol in resident physicians of internal medicine; among the possible reasons for this change could be the conditions of personal protection while treating patients, the uncertainty in the first months of not knowing how the virus was transmitted and not having or knowing when vaccinations would be available, as well as the lack of a strategy of adequate mental health support from the institutions dedicated to their academic training.

show abstract

Spanish version of the Substance Use Risk Profile Scale: Factor structure, reliability, and validity in Mexican adolescents

Robles-García

Fresán

Castellanos‐Ryan

et al. 2014

Psychiatry Research

View full text Add to dashboard Cite

Consistencia interna y estructura factorial de la Escala de Desesperanza de Beck en estudiantes mexicanos

Cited by 9 publications

References 27 publications

The Efficacy and Usability of an Unguided Web-Based Grief Intervention for Adults Who Lost a Loved One During the COVID-19 Pandemic: Randomized Controlled Trial

The Efficacy and Usability of an Unguided Web-Based Grief Intervention for Adults Who Lost a Loved One During the COVID-19 Pandemic: Randomized Controlled Trial

Depression symptoms and suicide risk of internal medicine residents before and after first year of the COVID-19 pandemic

Spanish version of the Substance Use Risk Profile Scale: Factor structure, reliability, and validity in Mexican adolescents

Contact Info

Product

Resources

About